MONOGRAPH LIBRARY
Brain, focus, mood, anxiety, depression, neuroprotection, nootropics.
Essential water-soluble vitamins supporting energy metabolism, neurological function, and stress resilience
Bupropion-naltrexone sustained-release (brand name Contrave) is an FDA-approved combination weight-loss drug, approved in September 2014. It pairs bupropion — a norepinephrine and dopamine reuptake inhibitor used as an antidepressant and…
Cerebrolysin is a parenteral pharmaceutical preparation of low-molecular-weight peptides and free amino acids derived from enzymatically processed porcine brain tissue. Manufactured by EVER Pharma since the 1970s, it is approved in more than 40…
Angiotensin IV Analog With No Human Safety Data
Ketamine is an NMDA-receptor antagonist that has been on the U.S. market as an anesthetic since 1970. In the early 2000s, NIH-funded work demonstrated that sub-anesthetic doses (~0.5 mg/kg IV over 40 minutes) produce rapid and substantial…
An amino acid supporting relaxed focus, mental clarity, and stress resilience without sedation
Neuroprotective at 5-20mg daily; regulatory ambiguity between pharmaceutical lithium and supplements
The Age-Related Eye Disease Study (AREDS) and its successor AREDS2 are among the most rigorously conducted nutritional intervention trials in modern medicine. Funded by the National Eye Institute and conducted over more than two decades, the trials…
Antioxidant with cognitive enhancement potential, serotonin syndrome risk critical
Microdosing is the practice of taking sub-perceptual doses of a classical psychedelic — most commonly psilocybin (roughly 0.1–0.5 g of dried Psilocybe cubensis, or about 1–3 mg of pure psilocybin) or LSD (approximately 5–20 mcg) — every few days,…
Wakefulness promotion with schedule IV controls
Semax (a synthetic analog of the N-terminal fragment of ACTH 4-10) and Selank (a synthetic analog of tuftsin) were developed by Russian scientific research institutes beginning in the 1980s-1990s. Both are registered medications in Russia for…
Cellular antioxidant and glutathione precursor for robust defense
Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) is a synthetic dipeptide developed in Russia in the mid-1990s at the Institute of Pharmacology of the Russian Academy of Medical Sciences. It was developed as a more potent analogue of piracetam —…
γ-Aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the mammalian central nervous system. Oral GABA supplements have been marketed for decades for stress, anxiety, sleep, and general relaxation. The classical neuroscience…
Pinealon (Glu-Asp-Arg) is a synthetic tripeptide developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. It is part of the broader Khavinson 'short peptide' bioregulator program, which has…
Polygala tenuifolia (Chinese name: yuan zhi, 远志) is a perennial herb whose root has been used in traditional Chinese medicine for over two thousand years. Classical TCM indications focused on insomnia, restlessness, palpitations, cognitive…
The racetam family is the original modern nootropic drug class. Piracetam was synthesized by Corneliu Giurgea in 1964 in Belgium; the term "nootropic" itself was coined by Giurgea to describe what he believed piracetam to be. The class shares a…
Russian-Approved Anxiolytic Peptide (Tuftsin Analog)
Russian-Approved Neuroprotective Peptide (ACTH Analog)
Selective serotonin reuptake inhibitors (SSRIs) — fluoxetine, sertraline, citalopram, escitalopram, paroxetine, fluvoxamine — and the closely related SNRIs (venlafaxine, duloxetine) are among the most-prescribed medication classes in modern…
Endogenous Neuropeptide With Limited Clinical Evidence for CIRS
Non-regulated practice; device-free; evidence for stress reduction and parasympathetic activation
Unregulated wellness practice; no device approval; emerging evidence for relaxation and stress reduction
Licensed profession in many jurisdictions; no medical device; evidence for muscle tension and stress reduction
Neurofeedback
Protocol Guide Series | April 2026 | FOR VANGUARD MEMBERS ONLY — Cognitive Performance & Brain Health Protocol: From Daily Focus to Long-Term Neuroprotection
Rational multi-compound cognitive enhancement strategy balancing risk-benefit and individual variation
AHCC is a fermented shiitake (Lentinula edodes) mycelia extract produced exclusively by Amino Up Co., a Sapporo-based supplement manufacturer. It is sold under multiple consumer brand labels but is the same underlying ingredient in every product…
Bromantane (N-(2-adamantyl)-4-bromoaniline) is a Russian-developed compound classified as an 'actoprotector' — a class describing agents that increase physical and cognitive performance under stress without the side-effect profile of classical…
NSI-189 is a small-molecule compound developed by Neuralstem (now Seneca Biopharma) as a novel antidepressant working through neurogenic mechanisms — specifically, stimulation of hippocampal neurogenesis. It progressed through Phase 1 and Phase 2…
Phenibut (β-phenyl-γ-aminobutyric acid) is a Russian-developed compound first synthesized in the 1960s as an anxiolytic and is registered as a pharmaceutical in Russia, Ukraine, Belarus, and Latvia for conditions including anxiety, insomnia, and…
Salidroside is the most-studied bioactive in rhodiola — and, as of 2024, finally available as a fermentation-derived isolated compound. One small Phase II RCT exists; everything else lives in the whole-extract literature. What the data actually say.
The racetam class — defined by a 2-pyrrolidinone (2-oxopyrrolidinyl) core structure — was the first and remains the most consequential synthetic nootropic class. Piracetam was synthesized by Corneliu Giurgea at UCB Pharma in 1964 and coined the term…
Bug report, content request, or general comment — we read everything.